InvestorsHub Logo
icon url

rafunrafun

11/18/18 12:44 PM

#160770 RE: bfost #160766

What I'm mostly looking forward to seeing is that relationship between EPA in blood level (or EPA/AA) to the event rate.... is it the bigger the better.... is there an optimum level?

I can see some doctors wanting to see that before converting to a EPA fan.
icon url

jfmcrr

11/18/18 7:25 PM

#160840 RE: bfost #160766

Yes RAF. They will be doing a deep dive on all bio markers and we will be hearing much more detail in the future. Could be very interesting and valuable clinical information that will help guide treatment, patient selection and MOA. Exciting stuff.



In a "Publish or perish"/"The next big thing"/"What's hot this very second" world, metering out publications to stay busy/keep it fresh, is a fact of life. The other side is that is that the "once in a lifetime/complete in all times/directions/dimensions can get overrun by everyone else working along the same lines.

Given the successful launch of V as expected here, there will be the funds and rationales to not only further data parse from Reduce It, but possibly initiate further small scale studies to fill in; See blood issue studies that cannot be done with RI banked blood samples.... quoted by Bhatt in something I read today.